6-((3R)-3-HYDROXY-1-PYRROLIDINYL)-5-(1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-PYRAZOL-5-YL)-N-(4-(TRIFLUOROMETHOXY)PHENYL)-3-PYRIDINECARBOXAMIDE
UNII QC4XYZ8AGY
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-((3r)-3-hydroxy-1-pyrrolidinyl)-5-(1-(tetrahydro-2h-pyran-2-yl)-1h-pyrazol-5-yl)-n-(4-(trifluoromethoxy)phenyl)-3-pyridinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QC4XYZ8AGY.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1492954-20-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H26F3N5O4 SGYQBYZEPALQNE-ZZWBGTBQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-((3r)-3-hydroxy-1-pyrrolidinyl)-5-(1-(tetrahydro-2h-pyran-2-yl)-1h-pyrazol-5-yl)-n-(4-(trifluoromethoxy)phenyl)-3-pyridinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.